1. A Randomized Phase II Trial (TAMIGA) Evaluating the Efficacy and Safety of Continuous Bevacizumab Through Multiple Lines of Treatment for Recurrent Glioblastoma. (28th September 2018) Authors: Brandes, Alba A.; Gil‐Gil, Miguel; Saran, Frank; Carpentier, Antoine F.; Nowak, Anna K.; Mason, Warren; Zagonel, Vittorina; Dubois, François; Finocchiaro, Gaetano; Fountzilas, George; Cernea, Dana Michaela; Chinot, Oliver; Anghel, Rodica; Ghiringhelli, Francois; Beauchesne, Patrick; Lombardi, Giu... Journal: Oncologist Issue: Volume 24:Number 4(2019) Page Start: 521 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗